Joseph Sullivan, MD, University of California, San Francisco, CA, reviews early POLARIS gene therapy trial data in Dravet syndrome, highlighting favorable safety, dose-dependent seizure reduction, and emerging improvements in communication and cognitive development compared with natural history.
advertisement
Key Highlights from POLARIS Gene Therapy Trial Data for Dravet Syndrome
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Joseph Sullivan, MD, University of California, San Francisco, CA, reviews early POLARIS gene therapy trial data in Dravet syndrome, highlighting favorable safety, dose-dependent seizure reduction, and emerging improvements in communication and cognitive development compared with natural history.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?